Pharmaceutical advertising; prohibiting certain direct-to-consumer advertising; providing civil and criminal penalties. Effective date. Emergency.

Summary

The bill prohibits pharmaceutical companies from marketing prescription medicines directly to Oklahoma residents through TV, radio, print, online, or social media. Affected companies must file annual compliance reports, and violations can trigger fines up to $50,000 for a first offense, escalating to $100,000 misdemeanors or $500,000 felonies for repeated or egregious breaches. The measure seeks to protect public health by limiting misleading drug promotion.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share